Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, Thoracic Oncology

Kathryn Gold

MD

🏢UC San Diego Moores Cancer Center🌐USA

Associate Professor of Medicine

40
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kathryn Gold is a thoracic medical oncologist and clinical investigator with expertise in HER2 altered NSCLC and novel targeted therapies. She has contributed to registration trials of HER2 directed agents including poziotinib and trastuzumab deruxtecan. She leads investigator-initiated studies exploring HER2 biology in lung cancer.

Share:

🧪Research Fields 研究领域

HER2 NSCLC
thoracic oncology
clinical trials
targeted therapy
antibody drug conjugates

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kathryn Gold 的研究动态

Follow Kathryn Gold's research updates

留下邮箱,当我们发布与 Kathryn Gold(UC San Diego Moores Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment